Dr. Manjiri Bakre, a distinguished cell biologist and entrepreneur, founded OncoStem Diagnostics in 2011 with a mission to revolutionize cancer treatment. Her journey into the world of oncology diagnostics was deeply personal and driven by the loss of a close friend to breast cancer. This tragedy ignited a passion in Dr. Bakre to find a better way to understand cancer and predict its recurrence, leading to the creation of OncoStem Diagnostics.
Innovative Beginnings
OncoStem Diagnostics, based in Bengaluru, focuses on personalized cancer treatment through advanced diagnostics. The company’s flagship product, CanAssist Breast, is a groundbreaking test that predicts the risk of breast cancer recurrence, enabling tailored treatment plans for patients. This innovation reduces the need for chemotherapy in patients classified as low-risk, sparing them from the severe side effects associated with the treatment.
Funding and Recognition
The journey of OncoStem Diagnostics has been marked by significant milestones. In 2017, the company raised $6 million from Sequoia Capital India Advisors, which followed an initial investment of $3 million from Artiman Ventures in 2011. These funds have been instrumental in advancing research and development efforts, expanding the company’s reach, and automating their tests.
The company’s innovative work has not gone unnoticed. In 2021, OncoStem Diagnostics was honored with the Aegis Graham Bell Award in the Innovative Diagnostics category. This prestigious award, supported by the Ministry of Electronics and Information Technology and NITI Aayog, recognizes excellence in innovation and technology.
Expanding Horizons
OncoStem Diagnostics aims to develop effective tests for other types of cancer, including oral, brain, and colon cancers. The company’s central laboratory in Bengaluru processes tumor tissues collected from across India and neighboring countries, and there are plans to establish another central laboratory in Singapore to cater to new markets in Southeast Asia.
AI and Machine Learning in Cancer Detection
Dr. Bakre’s vision extends beyond traditional diagnostics. OncoStem leverages advanced machine learning algorithms to predict cancer recurrence. These algorithms analyze the proteomic fingerprint of tumors, offering a sophisticated method to classify patients as low or high risk for cancer relapse. This approach exemplifies how cutting-edge technology can significantly improve patient outcomes by providing precise and personalized treatment plans.
Challenges and Triumphs
Dr. Bakre’s entrepreneurial journey has not been without challenges, particularly in a field dominated by complex scientific and technical hurdles. However, her determination, combined with a strong support system and a talented team, has enabled OncoStem to thrive. Dr. Bakre emphasizes the importance of focus, confidence, and hard work in achieving one’s goals, advising aspiring entrepreneurs to stay resilient and committed to their vision.
A Vision for the Future
OncoStem Diagnostics is more than just a business; it is a beacon of hope for cancer patients. By developing affordable and accurate diagnostic tests, Dr. Bakre and her team are making significant strides in the fight against cancer. Their work not only aids in better treatment planning but also contributes to the broader goal of sustainable and personalized healthcare.
Through her inspiring journey, Dr. Manjiri Bakre exemplifies how passion, innovation, and perseverance can lead to groundbreaking advancements in medical science. Her story is a testament to the impact that dedicated individuals can have on improving lives and advancing human health.
